Clinical trial Recruiting at 2 sites Interventional Ages 7 to 35

Orthokeratology contact lenses with a 5 mm optic zone diameter

Official title: Evaluation of Orthokeratology Lenses With a 5MM Optic Zone Diameter

Run by CooperVision International Limited (CVIL) · NCT07751172 · Data updated 2026-11-12

This study tests Paragon CRT lenses with a 5 mm optic zone in kids and young adults to see how well they fit, how well they vision, and how comfortable they are at night.

More Myopia trials

Quick facts

Study typeInterventional
Ages7 Years to 35 Years
SexAll
Enrollment70 (estimated)
SponsorCooperVision International Limited (CVIL)
Industry-sponsored
Locations3 sites (Pleasanton, California and 2 other locations)
StatusRecruiting
StartedAugust 14, 2026
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedOctober 22, 2026
Trial IDNCT07751172 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and young adults aged 6 to 35 with myopic refractive error (-0.50 to -6.00 D) and cylindrical error up to -1.75 D, who meet health and consent criteria and are willing to wear lenses overnight.

Probably not a fit

Individuals outside the refractive or astigmatic ranges, or those unable to comply with the nightly wear or visit schedule, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, multi-site interventional study evaluates the first-fit success, visual performance, and ocular health of 5 mm optic zone diameter orthokeratology lenses worn overnight. Participants have myopia with astigmatism and meet specific refractive and health criteria. The trial uses a single lens type (paflufocon D) and follows a defined wear and visit schedule to assess clinical outcomes and user-reported experience. Data will focus on lens fitting success, vision quality, and safety over the study period.

Why it matters

Potential benefit: If successful, the approach could provide effective overnight correction for myopia and astigmatism with a larger optic zone option.

How similar studies have gone: Previous orthokeratology studies have shown variable success; this specifically tests a 5 mm OZD design with empirical fitting to assess performance.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

A person is eligible for inclusion in the study if they:

1. Are 6- 35 years of age
2. If under 18 years old they are accompanied by a parent or legal guardian who is able to read, understand and sign the parental information and permission document
3. Have had a self-reported visual exam in the last two years
4. Are able to read (or be read to), understand and sign the assent document if under 18 years old or are able to read, understand and sign the consent document if aged 18 or older
5. Are willing to comply with the wear schedule (approximately 8 hours per night for every night, while sleeping)
6. Are willing to comply with the visit schedule
7. Have a refractive spherical component of their prescription between -0.50 and up to -6.00 diopters (inclusive) AND a refractive cylinder of no more than -1.75 diopters
8. Have a refractive spherical component ≥ cylinder component
9. Have a minimum visual acuity of +0.20 logMAR with each eye, when refracted at the Screening visit
10. Have clear corneas and no active ocular disease.
11. Have no medication, medical condition, or ocular conditions that contraindicate contact lens wear OR are expected to affect lens comfort or vision across the 1-month study duration, in the opinion of the investigator
12. Can be shown to have stable keratometry for at least the previous 1 month, if they have previously worn orthokeratology lenses.

Exclusion Criteria:

1. Present at screening visit with the presence of ocular or systemic disease or report the use medications which might interfere with orthokeratology contact lens wear, such as keratoconus, diabetes mellitus, steroid eye drops
2. Have a post-treatment predicted flat K value ≤38.00D (e.g. Patient baseline flat keratometry value = 40.00, patient has 2.00D of myopic refractive error. 40.00-2.00= 38.00D)
3. Have a known sensitivity to the diagnostic sodium fluorescein to be used in the study
4. Are pregnant, planning a pregnancy or lactating
5. Have amblyopia
6. Have presbyopia or has dependence on spectacles for near work over the contact lenses
7. Present at screening visit with the presence of clinically significant (grade ≥3; ISO scale) anterior segment abnormalities.
8. Present at screening visit with slit lamp findings that would contraindicate orthokeratology contact lens wear such as:

1\. Pathological dry eye or associated findings 2. Pterygium, pinguecula, or corneal scars within the visual axis 3. Neovascularization \> 0.75 mm from of the limbus 4. Giant papillary conjunctivitis (GPC) worse than grade 1 5. Anterior uveitis or iritis (past or present) 6. Seborrheic eczema, Seborrheic conjunctivitis 7. History of corneal ulcers or fungal infections 8. Poor personal hygiene 9. Aphakia

Where it's running

  • Treehouse Eyes Pleasanton Center
    Pleasanton, California, United States
    Recruiting
  • Bellaire Family Eye Care
    Bellaire, Texas, United States
    Recruiting
  • Complutense University of Madrid Av.
    Madrid, Moncloa - Aravaca,, Spain
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.